47
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3563629
Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression.
Steven McKnight: Co-Founder, Director of Research
Yasunori Kaneko: Business Executive
About the Company
Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression.
The company is considered a pioneer in the field of cell signaling and the control of gene expression. The company is focused primarily of three main areas; inflammation, metabolic diseases and oncology.
Tularik was founded by David Goeddel along with Steve McKnight and Robert Tjian in 1991.
The company was acquired by Amgen for US$ 1.3 billion in 2004.
